Roflumilast lowers inflammation markers within the airways. Daily use helps keep breathing passages open, reducing the occurrence of episodes that make getting enough air difficult.
Roflumilast belongs to a class of drugs called phosphodiesterase-4 (PDE4) inhibitors, which target pathways involved in airway inflammation. It is the active compound found in products marketed under the name Roflumilast.
Roflumilast reduces the inflammatory response in the lungs, lessening the chance of sudden worsening of breathing problems. Inflammation is a key driver of symptoms in conditions like chronic obstructive pulmonary disease (COPD).
Roflumilast is commonly used to:
Adults with a history of repeated COPD exacerbations often find roflumilast useful as part of their broader treatment plan.
Roflumilast blocks an enzyme (PDE4) that signals cells to release inflammatory chemicals. With that signal reduced, swelling and mucus production in the lungs decrease. Fewer sudden breathing episodes and more stable day-to-day function can follow.
Pregnant or nursing individuals, people with severe liver disease, and those with a history of certain heart rhythm problems should discuss alternative options with their health team.
Alcohol can increase the chance of side effects, and strong inhibitors of the enzyme CYP1A2, found in some antibiotics and antifungal drugs, may raise roflumilast levels in the body. Review your full medication list, including over-the-counter products, to spot potential interactions. For precise interaction details, always refer to your medication's labeling.
Older adults, especially those with existing liver problems or who are taking multiple medicines that affect the same liver enzyme, tend to notice side effects more often. People with a history of mood disorders may also be more sensitive to the emotional changes linked to roflumilast.
Keep roflumilast tablets in a cool, dry place away from direct sunlight and moisture. Typical formulations are intended for long-term daily use, though the exact duration depends on your individual treatment plan. Different brands of roflumilast may vary in strength, so always follow the instructions that come with your specific product.
For Roflumilast-specific instructions, refer to the medication information supplied with the product.
PDE4: An enzyme that helps control inflammation; blocking it can reduce swelling in the lungs. Exacerbation: A sudden worsening of symptoms, such as increased coughing or shortness of breath. Bronchitis: Inflammation of the airway lining that leads to excess mucus and a chronic cough. CYP1A2: A liver protein that helps break down certain medicines; some drugs can slow it down, raising levels of roflumilast.
This article provides an educational overview of roflumilast, not medical advice. Medicines containing this ingredient (Roflumilast) may differ in formulation, strength, and directions. The information here does not replace professional clinical judgment. Readers should review their specific medication's labeling and seek guidance from a healthcare professional.
